BiotechTubeBiotechTube
Home/Soleno Therapeutics/Mark Hahn
MH

Mark Hahn

Board Member

Soleno Therapeutics

Therapeutic Areas

Rare Genetic DisordersPrader-Willi Syndrome

Soleno Therapeutics Pipeline

DrugIndicationPhase
VYKAT XRHyperphagia in Prader-Willi SyndromeApproved/Commercial

Leadership Team at Soleno Therapeutics

AB
Anish Bhatnagar, MD
Chairman of the Board and Chief Executive Officer
LB
Lauren Budesheim
Senior Vice President, People
NM
Neil M. Cowen, PhD, MBA
Senior Vice President, New Product Planning
DC
Dawn Carter Bir
Board Member
View full Soleno Therapeutics profile